Alnylam Pharmaceuticals, Inc. (ALNY) stock
ALNYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 10/3048% below fair value
$143.82−4.00 (-2.71%)
Close on Nov 20, 2026Market cap $19.26BP/E 7.5Yield –
Alnylam Pharmaceuticals pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Alnylam Pharmaceuticals's pe ratio was 28.1× on Nov 11, 2026, against 564.0× a year earlier.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 28.1× | −468.9 |
| 2025 | Dec 31, 2025 | 497.1× | – |
See a number that looks wrong?